Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA alkylation is a type of DNA damage resulting from the covalent addition of alkyl groups to DNA bases or the phosphodiester backbone. This modification can disrupt DNA replication and transcription, leading to mutations, cell death, and cancer. It is also a target for several chemotherapeutic agents that induce DNA damage in rapidly dividing cells. Repair mechanisms such as MGMT and BER play a crucial role in mitigating the effects of alkylation.
Covalent modification of DNA bases or phosphodiester backbone, leading to DNA damage, replication block, transcription stalling, and cell death.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deoxyribonucleic Acid Alkylation (DNA Alkylation).